- Home
- LRFC vs KZR Comparison
LRFC vs KZR Comparison
Compare LRFC & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRFC
- KZR
- Stock Information
- Founded
- LRFC 2013
- KZR 2015
- Country
- LRFC United States
- KZR United States
- Employees
- LRFC N/A
- KZR N/A
- Industry
- LRFC Finance: Consumer Services
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- LRFC Finance
- KZR Health Care
- Exchange
- LRFC Nasdaq
- KZR Nasdaq
- Market Cap
- LRFC 68.2M
- KZR 65.3M
- IPO Year
- LRFC 2013
- KZR 2018
- Fundamental
- Price
- LRFC $25.30
- KZR $7.53
- Analyst Decision
- LRFC
- KZR Hold
- Analyst Count
- LRFC 0
- KZR 2
- Target Price
- LRFC N/A
- KZR $11.00
- AVG Volume (30 Days)
- LRFC 7.2K
- KZR 61.7K
- Earning Date
- LRFC 11-07-2024
- KZR 11-12-2024
- Dividend Yield
- LRFC 5.22%
- KZR N/A
- EPS Growth
- LRFC N/A
- KZR N/A
- EPS
- LRFC N/A
- KZR N/A
- Revenue
- LRFC $19,936,000.00
- KZR N/A
- Revenue This Year
- LRFC $3.13
- KZR N/A
- Revenue Next Year
- LRFC $1.47
- KZR $66.68
- P/E Ratio
- LRFC N/A
- KZR N/A
- Revenue Growth
- LRFC N/A
- KZR N/A
- 52 Week Low
- LRFC $19.82
- KZR $5.20
- 52 Week High
- LRFC $25.74
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- LRFC 59.48
- KZR 49.59
- Support Level
- LRFC $24.77
- KZR $7.27
- Resistance Level
- LRFC $25.40
- KZR $7.50
- Average True Range (ATR)
- LRFC 0.65
- KZR 0.48
- MACD
- LRFC -0.02
- KZR -0.08
- Stochastic Oscillator
- LRFC 74.57
- KZR 40.00
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.